Government’s focus on R&D activities in healthcare and increasing approvals for manufacture of generic drugs to drive United States soft tissue sarcoma market According to TechSci Research report, “United States Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type (Local Sarcoma, Regional Sarcoma, Metastatic Sarcoma), By End User (Hospitals, Oncology Center,